Neurotropin [NT3] for acute dental pain and for chronic neuropathic pain.
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Neurotropin (Primary)
- Indications Complex regional pain syndromes; Dental pain
- Focus Therapeutic Use
- 22 Jun 2012 Planned end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 21 Jun 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 06 Jun 2012 Additional lead trial investigator (John D Heiss) identified as reported by ClinicalTrials.gov.